Most focused longevity play with 90 companies targeting senior citizen health, but faces challenges including small asset base ($81 million), low liquidity, higher expense ratio (0.50%), and underperformance in 2026 YTD. Best suited as a long-term thematic bet.
Articles that tag AGNG but are mainly about other companies.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology